What is the management approach for a patient with a benign common bile duct (CBD) stricture, possibly related to a passed stone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Benign CBD Stricture

Endoscopic therapy with temporary placement of multiple plastic stents over a prolonged period is the first-line treatment for benign CBD strictures, achieving success rates of 74-90%, though recurrence occurs in up to 30% of patients within 2 years of stent removal. 1

Etiology: Can a Passed Stone Cause Stricture?

Yes, a passed stone can absolutely cause benign CBD stricture through several mechanisms:

  • Stone-related trauma: Stones can cause direct injury to the bile duct wall during passage, leading to inflammation, fibrosis, and subsequent stricture formation 2, 3
  • Perforation and inflammation: Stone perforation through the duct wall triggers intense inflammatory response and scarring 3
  • Chronic obstruction: Long-standing stones cause upstream inflammation and fibrosis even after passage 2
  • Secondary biliary cirrhosis: Untreated or recurrent stone-related strictures can progress to secondary biliary cirrhosis if left unmanaged 2

Initial Diagnostic Approach

Trans-abdominal ultrasound and liver function tests are recommended as initial evaluation, but normal results do not exclude stricture if clinical suspicion remains high. 1

  • Look specifically for: biliary dilation, wall thickening, jaundice, elevated alkaline phosphatase and bilirubin 1, 4
  • Advanced imaging with MRCP or EUS is indicated when initial tests are inconclusive but suspicion persists 1, 5
  • ERCP provides both diagnostic visualization and therapeutic intervention 1

First-Line Endoscopic Management

Multiple plastic stent placement is the preferred initial treatment strategy:

  • Stent protocol: Place multiple plastic stents (typically 2-4) to maximize dilation of the stricture 1
  • Duration: Stents remain in place for 4-8 weeks initially, with serial exchanges every 3 months 1
  • Total treatment duration: Continue stenting for 12 months or longer to achieve optimal long-term patency 1
  • Success rates: 74-90% initial success, but 30% recurrence within 2 years after stent removal 1

For strictures >2 cm from the hepatic confluence, fully covered self-expanding metal stents (SEMS) are an alternative to plastic stents. 1

When Strictures Are Recognized Early

  • Early post-injury strictures (recognized within weeks of the inciting event) respond more favorably to endoscopic treatment than delayed fibrotic strictures 1
  • These are often associated with bile leak and respond better because fibrosis is less established 1
  • Aggressive early treatment prevents progression to dense fibrotic strictures 1

Follow-Up Protocol

Structured surveillance is essential given the 30% recurrence rate:

  • During stenting: ERCP with cholangiography every 3 months for stent exchange 1
  • After stent removal: Repeat cholangiography at stent removal to confirm resolution 1
  • Post-treatment surveillance: Monitor liver function tests every 3-6 months for the first 2 years 1
  • Clinical monitoring: Watch for recurrent symptoms (jaundice, cholangitis, right upper quadrant pain) that suggest re-stricturing 4
  • Imaging if symptomatic: Obtain MRCP or repeat ERCP if liver enzymes rise or symptoms recur 1, 5

Alternative Approaches When ERCP Fails

Percutaneous transhepatic biliary drainage (PTBD) is the next option when endoscopic access fails:

  • Technical success rate of 90% in expert centers 1
  • Short-term clinical success of 70-80% 1
  • Particularly useful for complete obstructions with sepsis 1
  • Can be more difficult with non-dilated ducts but still achievable 1

Surgical Management

Surgery is reserved for endoscopic failures or complex strictures:

  • Roux-en-Y hepaticojejunostomy is the definitive surgical repair for refractory strictures 1
  • Referral to a hepatobiliary surgeon is essential—non-specialist repairs have higher failure rates 1
  • Surgical repair shows superior 5-year outcomes when performed by experienced HPB surgeons 1

Critical Pitfalls to Avoid

  • Don't stop surveillance after stent removal: The 30% recurrence rate within 2 years means ongoing monitoring is mandatory 1
  • Don't delay treatment: Untreated strictures can progress to secondary biliary cirrhosis and liver failure 2
  • Don't attempt surgical repair without HPB expertise: Non-specialist repairs have significantly higher morbidity and mortality 1
  • Don't assume normal LFTs exclude stricture: Maintain high clinical suspicion even with normal labs if symptoms suggest biliary obstruction 1, 4
  • Don't use stenting as definitive treatment in young, healthy patients: Consider surgical repair for better long-term outcomes in appropriate candidates 1

Special Consideration: Recurrent Stone Formation

  • Post-cholecystectomy patients with strictures are at risk for primary stone formation within the strictured segment 6
  • Stone extraction should be performed before or concurrent with stricture dilation 1, 6
  • Address both the stricture and any stones to prevent recurrent cholangitis 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Multidisciplinary approach to benign biliary strictures.

Current treatment options in gastroenterology, 2007

Guideline

Severity of Common Bile Duct Stones (CBDS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[The Management of Common Bile Duct Stones].

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2018

Guideline

Primary CBD Stones in Post-Cholecystectomy Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the cause of pain in a patient with an impacted stone in the Common Bile Duct (CBD) after a failed removal attempt, presenting with upper abdominal tenderness?
What are the management options for common bile duct (CBD) stones?
What is the treatment approach for a common bile duct (CBD) stone greater than 2cm?
What is the preferred surgical approach for large impacted common bile duct (CBD) stones greater than 2cm: choledochoduodenotomy, choledochojejunostomy, or hepaticojejunostomy?
What is the outpatient management approach for hepatic steatosis, calculous (inflammation of the gallbladder due to gallstones) cholecystitis, and a dilated Common Bile Duct (CBD)?
What is the recommended treatment for heat rash in an infant?
Can paracetamol (acetaminophen) suppositories exacerbate diarrhea in a 10-month-old infant with Acute Otitis Media (AOM) who is already experiencing diarrhea due to amoxicillin?
What is the appropriate dosing and monitoring strategy for an adult patient with a history of chronic pain or neurological disorders, possibly with impaired renal function, who is being considered for treatment with gabapentin enacarbil for conditions such as restless legs syndrome, postherpetic neuralgia, or epilepsy?
Can moderate physical activity and a history of pyelonephritis cause ambiguous results on a TEP (Technetium-99m Ethylene Dicysteine) scan, particularly with hypermetabolic lombo-aortic lymph nodes?
What is the role of neoadjuvant chemotherapy and immunotherapy in the treatment of gastric cancer, particularly in patients with locally advanced disease?
What can be taken with antibiotics to prevent yeast infections in patients at risk?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.